Skip to content
healthcare.dev

Itraconazole

NDC 16571-245, Itraconazole, capsule, from Rising Pharma Holdings, Inc..

Product NDC
16571-245
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205724
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-245 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ITRACONAZOLE100 mg/1

Pharmacologic classes

Azole Antifungal [EPC]; Azoles [CS]; Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
16571-245-031657102450330 CAPSULE in 1 BOTTLE (16571-245-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6df5ff94-47ba-4881-abb4-b321e35a6955
  • NADAC price for package 16571024503

    GET /v1/drugs/nadac/16571024503

Use it

Look up 16571-245 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-245 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-245. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.